Repositioning Candidate Details
| Candidate ID: | R1039 |
| Source ID: | DB06527 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | Tramiprosate |
| Synonyms: | Tramiprosate |
| Molecular Formula: | C3H9NO3S |
| SMILES: | NCCCS(O)(=O)=O |
| Structure: |
|
| DrugBank Description: | -- |
| CAS Number: | 3687-18-1 |
| Molecular Weight: | 139.173 |
| DrugBank Indication: | Investigated for use/treatment in strokes and alzheimer's disease. |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | -- |
| Inclusion Criteria: | Indication associated |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class | |
|---|---|---|---|---|---|
| I16 | 6713 | Cerebrovascular disease | An vascular disease that is characterized by dysfunction of the blood vessels supplying the brain. http://en.wikipedia.org/wiki/Cerebrovascular_disease, http://www.ncbi.nlm.nih.gov/books/NBK378/ | disease of anatomical entity/ cardiovascular system disease/ vascular disease/cerebrovascular disease | Details |